These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 29221819)
1. Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene. García-Cerro S; Vidal V; Lantigua S; Berciano MT; Lafarga M; Ramos-Cabrer P; Padro D; Rueda N; Martínez-Cué C Neurobiol Dis; 2018 Feb; 110():206-217. PubMed ID: 29221819 [TBL] [Abstract][Full Text] [Related]
2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes. García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome. García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425 [TBL] [Abstract][Full Text] [Related]
4. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts. Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335 [TBL] [Abstract][Full Text] [Related]
5. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner. Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111 [TBL] [Abstract][Full Text] [Related]
6. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201 [TBL] [Abstract][Full Text] [Related]
7. A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome-associated kinase Dyrk1A overexpression. Buchberger A; Schepergerdes L; Flaßhoff M; Kunick C; Köster RW J Biol Chem; 2021 Jul; 297(1):100853. PubMed ID: 34090874 [TBL] [Abstract][Full Text] [Related]
8. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917 [TBL] [Abstract][Full Text] [Related]
9. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. McElyea SD; Starbuck JM; Tumbleson-Brink DM; Harrington E; Blazek JD; Ghoneima A; Kula K; Roper RJ Hum Mol Genet; 2016 Nov; 25(22):4856-4869. PubMed ID: 28172997 [TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes. Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033 [TBL] [Abstract][Full Text] [Related]
11. Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a. Blazek JD; Abeysekera I; Li J; Roper RJ Hum Mol Genet; 2015 Oct; 24(20):5687-96. PubMed ID: 26206885 [TBL] [Abstract][Full Text] [Related]
13. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome. Çağlayan ES Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462 [TBL] [Abstract][Full Text] [Related]
14. Increased NR2A expression and prolonged decay of NMDA-induced calcium transient in cerebellum of TgDyrk1A mice, a mouse model of Down syndrome. Altafaj X; Ortiz-Abalia J; Fernández M; Potier MC; Laffaire J; Andreu N; Dierssen M; González-García C; Ceña V; Martí E; Fillat C Neurobiol Dis; 2008 Dec; 32(3):377-84. PubMed ID: 18773961 [TBL] [Abstract][Full Text] [Related]
15. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134 [TBL] [Abstract][Full Text] [Related]
16. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome. Laguna A; Barallobre MJ; Marchena MÁ; Mateus C; Ramírez E; Martínez-Cue C; Delabar JM; Castelo-Branco M; de la Villa P; Arbonés ML Hum Mol Genet; 2013 Jul; 22(14):2775-84. PubMed ID: 23512985 [TBL] [Abstract][Full Text] [Related]
17. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339 [TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628 [TBL] [Abstract][Full Text] [Related]
19. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A. Nguyen TL; Duchon A; Manousopoulou A; Loaëc N; Villiers B; Pani G; Karatas M; Mechling AE; Harsan LA; Limanton E; Bazureau JP; Carreaux F; Garbis SD; Meijer L; Herault Y Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115750 [TBL] [Abstract][Full Text] [Related]
20. Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a. Marechal D; Brault V; Leon A; Martin D; Lopes Pereira P; Loaëc N; Birling MC; Friocourt G; Blondel M; Herault Y Hum Mol Genet; 2019 May; 28(9):1561-1577. PubMed ID: 30649339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]